China Growth Stocks

[nuketheshorts]

NKBP Began trading today.

Insights?

Achievements & Honors
On January 2009
Nuokang Bio-pharmaceutical was short-listed on “Forbes China most potential small and medium- sized enterprises 2009”.
On December 2008
Penglai Nuokang Bio-pharmaceutical Co. Ltd. was accredited as New-high Technology Corporation by Science and Technology Department of Shandong Province.
On December 2008
Liaoning Nuokang Bio-pharmaceutical Co. Ltd. was accredited as New-high Technology Corporation by Science and Technology Department of Liaoning Province.
On December 2008
Nuokang Bio-phaemaceutical was honored as “2008 China Most Potential Development Healthcare Enterprises” in the Third China Healthcare Industry Investment Summit.
On November 2008
The Hemocoagulase Atrox for Injection project, which was researched and developed by Liaoning Nuokang Bio-pharmaceutical Co., Ltd., was honored as Shenyang Revitalization of Science & Technology Development Award by Shenyang Municipal Government.
On March 2008
Liaoning Nuokang Bio-pharmaceutical Co., Ltd. was honored as “Good Employee Relation Enterprise of Shenyang City”.
On Janruary 2008
Penglai Nuokang Pharmaceutical Co., Ltd. was honored as “Good Employee Relation Enterprise of Yantai City”.
On December 2007
As strategic investors, Sequoia Capital China Fund, and HBM BioMed China invested USD17 million in Nuokang Group.
On August 2007
Liaoning Nuokang Bio-pharmaceutical Co. Ltd. was awarded as “Province Level Enterprise Technique Center” by Economic Committee of Liaoning Province.
On August 2007
Liaoning Nuokang Bio-pharmaceutical Co. Ltd. was accredited as “Post Doctor Science and Research Working Station” by Human Resource Bureau of Shenyang City.
On April 2006
The Hemocoagulase product of Liaoning Nuokang Bio-pharmaceutical Co., Ltd. won the Shenyang Municipal Second-class Award of Science and Technology Progress Prize.
On October 2005
Penglai Nuokang Pharmaceutical Co., Ltd. was evaluated as Grow-up Enterprise of Shandong Province.
On November 2003
Hemocoagulase Research project of Shenyang Sainuo Science & technology Development Co., Ltd. won the Third-class Award of Science and Technology Progress Prize of Liaoning Province.